The quest to align cost with care, enhance data visibility, and shed the dependence on outdated revenue streams.
Susan Thomas
Advertisement
Chief Commercial Officer, LucyRx
Articles by Susan Thomas
A look back and ahead at the growing trend—sparked recently by the GLP-1 trail—and new ways to harness this Rx access channel for positive outcomes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Merck Planning $70 Billion Investment for US Expansion
2
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
3
From Advantage to Essential: How Daily Data & AI Alerts Transform Commercial Functions
4
Navigating the Complexities of a Global Pharma Expansion
5
